DRMTLGY RADIANCE POWDER- titanium dioxide, zinc oxide powder

DRMTLGY Radiance Powder by

Drug Labeling and Warnings

DRMTLGY Radiance Powder by is a Otc medication manufactured, distributed, or labeled by DRMTLGY, Nanophase Technologies Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DRMTLGY Radiance Powder

DRMTLGY Radiance Powder

DRMTLGY Radiance Powder

DRMTLGY Radiance Powder

DRMTLGY Radiance Powder

DRMTLGY Radiance Powder

DRMTLGY Radiance Powder

DRMTLGY Radiance Powder

INGREDIENTS AND APPEARANCE

DRMTLGY RADIANCE POWDER 
titanium dioxide, zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 83286-191
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	0.125 g  in 1 g
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	0.225 g  in 1 g

Inactive Ingredients
Ingredient Name	Strength
GLYCERIN (UNII: PDC6A3C0OX)
TRIDECYL SALICYLATE (UNII: AZQ08K38Z1)
OCTYLDODECANOL (UNII: 461N1O614Y)
ISOCETETH-10 (UNII: 1K92T9919H)
PHENYLPROPANOL (UNII: 0F897O3O4M)
METHICONE (20 CST) (UNII: 6777U11MKT)
PHYSALIS ANGULATA (UNII: W4TKW9D5GG)
PROPANEDIOL (UNII: 5965N8W85T)
RESVERATROL (UNII: Q369O8926L)
GLYCYRRHIZA GLABRA (UNII: 2788Z9758H)
BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
NIACINAMIDE (UNII: 25X51I8RD4)
ISODECYL SALICYLATE (UNII: S7097PFP4C)
TOCOPHEROL (UNII: R0ZB2556P8)
MICA (UNII: V8A1AW0880)
DIMETHICONE (UNII: 92RU3N3Y1O)
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)

Product Characteristics
Color	brown	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83286-191-02	1 in 1 CARTON	03/18/2024
1	NDC: 83286-191-01	6.5 g in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	03/18/2024

Labeler - DRMTLGY (094762235)

Registrant - Nanophase Technologies Corporation (623502044)

Establishment
Name	Address	ID/FEI	Business Operations
Nanophase Technologies Corporation		050383046	api manufacture(83286-191)

Establishment
Name	Address	ID/FEI	Business Operations
Nanophase Technologies Corporation		118812921	manufacture(83286-191) , pack(83286-191)

Establishment
Name	Address	ID/FEI	Business Operations
Nanophase Technologies Corporation		623502044	api manufacture(83286-191) , manufacture(83286-191)